1. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.
Lancet Neurol 2010;9:167-176.
2. Shetty VS, Reis MN, Aulino JM, Berger KL, Broder J, Choudhri AF, et al. ACR appropriateness criteria head trauma.
J Am Coll Radiol 2016;13:668-679.
3. Orrison WW, Gentry LR, Stimac GK, Tarrel RM, Espinosa MC, Cobb LC. Blinded comparison of cranial CT and MR in closed head injury evaluation.
AJNR Am J Neuroradiol 1994;15:351-356.
4. Lee H, Wintermark M, Gean AD, Ghajar J, Manley GT, Mukherjee P. Focal lesions in acute mild traumatic brain injury and neurocognitive outcome: CT versus 3T MRI.
J Neurotrauma 2008;25:1049-1056.
5. Altmeyer W, Steven A, Gutierrez J. Use of magnetic resonance in the evaluation of cranial trauma.
Magn Reson Imaging Clin N Am 2016;24:305-323.
6. Mirvis SE, Shanmuganathan K. Trauma radiology: part IV. Imaging of acute craniocerebral trauma.
J Intensive Care Med 1994;9:305-315.
7. Marder CP, Narla V, Fink JR, Tozer Fink KR. Subarachnoid hemorrhage: beyond aneurysms.
AJR Am J Roentgenol 2014;202:25-37.
8. Aminmansour B, Ghorbani A, Sharifi D, Shemshaki H, Ahmadi A. Cerebral vasospasm following traumatic subarachnoid hemorrhage.
J Res Med Sci 2009;14:343-348.
9. Armin SS, Colohan AR, Zhang JH. Vasospasm in traumatic brain injury.
Acta Neurochir Suppl 2008;104:421-425.
10. da Rocha AJ, da Silva CJ, Gama HP, Baccin CE, Braga FT, Cesare Fde A, et al. Comparison of magnetic resonance imaging sequences with computed tomography to detect low-grade subarachnoid hemorrhage: role of fluid-attenuated inversion recovery sequence.
J Comput Assist Tomogr 2006;30:295-303.
11. Noguchi K, Ogawa T, Inugami A, Toyoshima H, Sugawara S, Hatazawa J, et al. Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences.
Radiology 1995;196:773-777.
12. Shimoda M, Hoshikawa K, Shiramizu H, Oda S, Matsumae M. Problems with diagnosis by fluid-attenuated inversion recovery magnetic resonance imaging in patients with acute aneurysmal subarachnoid hemorrhage.
Neurol Med Chir (Tokyo) 2010;50:530-537.
13. Verma RK, Kottke R, Andereggen L, Weisstanner C, Zubler C, Gralla J, et al. Detecting subarachnoid hemorrhage: comparison of combined FLAIR/SWI versus CT.
Eur J Radiol 2013;82:1539-1545.
14. Talbott JF, Gean A, Yuh EL, Stiver SI. Calvarial fracture patterns on CT imaging predict risk of a delayed epidural hematoma following decompressive craniectomy for traumatic brain injury.
AJNR Am J Neuroradiol 2014;35:1930-1935.
15. Ganz JC. The lucid interval associated with epidural bleeding: evolving understanding.
J Neurosurg 2013;118:739-745.
16. Ivamoto HS, Lemos HP Jr, Atallah AN. Surgical treatments for chronic subdural hematomas: a comprehensive systematic review.
World Neurosurg 2016;86:399-418.
17. Wei SC, Ulmer S, Lev MH, Pomerantz SR, González RG, Henson JW. Value of coronal reformations in the CT evaluation of acute head trauma.
AJNR Am J Neuroradiol 2010;31:334-339.
18. Zacharia TT, Nguyen DT. Subtle pathology detection with multidetector row coronal and sagittal CT reformations in acute head trauma.
Emerg Radiol 2010;17:97-102.
19. Lee EJ, Hung YC, Wang LC, Chung KC, Chen HH. Factors influencing the functional outcome of patients with acute epidural hematomas: analysis of 200 patients undergoing surgery.
J Trauma 1998;45:946-952.
20. Martin RM, Wright MJ, Lutkenhoff ES, Ellingson BM, Van Horn JD, Tubi M, et al. Traumatic hemorrhagic brain injury: impact of location and resorption on cognitive outcome.
J Neurosurg 2016;27:1-9.
21. Wardlaw JM, Statham PF. How often is haemosiderin not visible on routine MRI following traumatic intracerebral haemorrhage?
Neuroradiology 2000;42:81-84.
22. Moen KG, Skandsen T, Folvik M, Brezova V, Kvistad KA, Rydland J, et al. A longitudinal MRI study of traumatic axonal injury in patients with moderate and severe traumatic brain injury.
J Neurol Neurosurg Psychiatry 2012;83:1193-1200.
23. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation.
Lancet Neurol 2009;8:165-174.
24. Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength.
AJNR Am J Neuroradiol 2009;30:338-343.
25. Kampfl A, Schmutzhard E, Franz G, Pfausler B, Haring HP, Ulmer H, et al. Prediction of recovery from post-traumatic vegetative state with cerebral magnetic-resonance imaging.
Lancet 1998;351:1763-1767.
26. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, et al. Proportion of different subtypes of stroke in china.
Stroke 2003;34:2091-2096.
27. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage.
Stroke 2001;32:891-897.
28. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality.
Stroke 1993;24:987-993.
29. Cheung RT, Zou LY. Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage.
Stroke 2003;34:1717-1722.
30. Hallevi H, Dar NS, Barreto AD, Morales MM, Martin-Schild S, Abraham AT, et al. The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications.
Crit Care Med 2009;37:969-974. e1.
31. Steiner T, Diringer MN, Schneider D, Mayer SA, Begtrup K, Broderick J, et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
Neurosurgery 2006;59:767-773. discussion 773-774.
32. Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT).
Stroke 2010;41:307-312.
33. Diringer MN, Ferran JM, Broderick J, Davis S, Mayer SA, Steiner T, et al. Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage.
Cerebrovasc Dis 2007;24:219-225.
34. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
Neurology 2006;66:1175-1181.
35. Romero JM, Heit JJ, Delgado Almandoz JE, Goldstein JN, Lu J, Halpern E, et al. Spot sign score predicts rapid bleeding in spontaneous intracerebral hemorrhage.
Emerg Radiol 2012;19:195-202.
36. Romero JM, Brouwers HB, Lu J, Delgado Almandoz JE, Kelly H, Heit J, et al. Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage.
Stroke 2013;44:3097-3102.
37. Delgado Almandoz JE, Yoo AJ, Stone MJ, Schaefer PW, Oleinik A, Brouwers HB, et al. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors.
Stroke 2010;41:54-60.
38. Kim J, Smith A, Hemphill JC 3rd, Smith WS, Lu Y, Dillon WP, et al. Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage.
AJNR Am J Neuroradiol 2008;29:520-525.
39. Field DK, Kleinig TJ. Aura attacks from acute convexity subarachnoid haemorrhage not due to cerebral amyloid angiopathy.
Cephalalgia 2011;31:368-371.
40. Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum.
J Neurol Neurosurg Psychiatry 2012;83:124-137.
41. Linn J. Imaging of cerebral microbleeds.
Clin Neuroradiol 2015;25 Suppl 2:167-175.
42. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
Neurology 2001;56:537-539.
43. Gregoire SM, Charidimou A, Gadapa N, Dolan E, Antoun N, Peeters A, et al. Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study.
Brain 2011;134:2376-2386.
44. Fisher M, French S, Ji P, Kim RC. Cerebral microbleeds in the elderly: a pathological analysis.
Stroke 2010;41:2782-2785.
45. Zhang J, Yang Y, Sun H, Xing Y. Hemorrhagic transformation after cerebral infarction: current concepts and challenges.
Ann Transl Med 2014;2:81.
46. Sussman ES, Connolly ES Jr. Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke.
Front Neurol 2013;4:69.
47. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke.
Stroke 2011;42:2235-2239.
48. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group.
Stroke 1999;30:1326-1332.
49. Berger C, Fiorelli M, Steiner T, Schäbitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?
Stroke 2001;32:1330-1335.
50. Kablau M, Kreisel SH, Sauer T, Binder J, Szabo K, Hennerici MG, et al. Predictors and early outcome of hemorrhagic transformation after acute ischemic stroke.
Cerebrovasc Dis 2011;32:334-341.
51. Lindley RI, Wardlaw JM, Sandercock PA, Rimdusid P, Lewis SC, Signorini DF, et al. Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction.
J Stroke Cerebrovasc Dis 2004;13:235-246.
52. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.
AJNR Am J Neuroradiol 1993;14:3-13.
53. Gupta R, Phan CM, Leidecker C, Brady TJ, Hirsch JA, Nogueira RG, et al. Evaluation of dual-energy CT for differentiating intracerebral hemorrhage from iodinated contrast material staining.
Radiology 2010;257:205-211.
54. Brisman JL, Song JK, Newell DW. Cerebral aneurysms.
N Engl J Med 2006;355:928-939.
55. Perry JJ, Stiell IG, Sivilotti ML, Bullard MJ, Emond M, Symington C, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study.
BMJ 2011;343:d4277.
56. Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale.
Neurosurgery 2006;59:21-27. discussion 21-27.
57. Friedlander RM. Clinical practice. Arteriovenous malformations of the brain.
N Engl J Med 2007;356:2704-2712.
58. Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.
Lancet 2014;383:614-621.
59. Hofmeister C, Stapf C, Hartmann A, Sciacca RR, Mansmann U, terBrugge K, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation.
Stroke 2000;31:1307-1310.
60. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment.
J Neurosurg 1990;73:387-391.
61. Stapf C, Mohr JP, Pile-Spellman J, Solomon RA, Sacco RL, Connolly ES Jr. Epidemiology and natural history of arteriovenous malformations.
Neurosurg Focus 2001;11:e1.
62. Lv X, Liu J, Hu X, Li Y. Patient age, hemorrhage patterns, and outcomes of arteriovenous malformation.
World Neurosurg 2015;84:1039-1044.
63. Lasjaunias P, Chiu M, ter Brugge K, Tolia A, Hurth M, Bernstein M. Neurological manifestations of intracranial dural arteriovenous malformations.
J Neurosurg 1986;64:724-730.
64. Hacein-Bey L, Konstas AA, Pile-Spellman J. Natural history, current concepts, classification, factors impacting endovascular therapy, and pathophysiology of cerebral and spinal dural arteriovenous fistulas.
Clin Neurol Neurosurg 2014;121:64-75.
65. Serulle Y, Miller TR, Gandhi D. Dural arteriovenous fistulae: imaging and management.
Neuroimaging Clin N Am 2016;26:247-258.
66. Biswas S, Chandran A, Radon M, Puthuran M, Bhojak M, Nahser HC, et al. Accuracy of four-dimensional CT angiography in detection and characterisation of arteriovenous malformations and dural arteriovenous fistulas.
Neuroradiol J 2015;28:376-384.
67. Jagadeesan BD, Delgado Almandoz JE, Benzinger TL, Moran CJ. Postcontrast susceptibility-weighted imaging: a novel technique for the detection of arteriovenous shunting in vascular malformations of the brain.
Stroke 2011;42:3127-3131.
68. Soize S, Bouquigny F, Kadziolka K, Portefaix C, Pierot L. Value of 4D MR angiography at 3T compared with DSA for the follow-up of treated brain arteriovenous malformation.
AJNR Am J Neuroradiol 2014;35:1903-1909.
69. Sunwoo L, Sohn CH, Lee JY, Yi KS, Yun TJ, Choi SH, et al. Evaluation of the degree of arteriovenous shunting in intracranial arteriovenous malformations using pseudo-continuous arterial spin labeling magnetic resonance imaging.
Neuroradiology 2015;57:775-782.
70. Jain NK, Kannath SK, Kapilamoorthy TR, Thomas B. The application of susceptibility-weighted MRI in pre-interventional evaluation of intracranial dural arteriovenous fistulas.
J Neurointerv Surg 2016;pii:neurintsurg-2016-012314.
71. Le TT, Fischbein NJ, André JB, Wijman C, Rosenberg J, Zaharchuk G. Identification of venous signal on arterial spin labeling improves diagnosis of dural arteriovenous fistulas and small arteriovenous malformations.
AJNR Am J Neuroradiol 2012;33:61-68.
72. Amukotuwa SA, Heit JJ, Marks MP, Fischbein N, Bammer R. Detection of cortical venous drainage and determination of the Borden type of dural arteriovenous fistula by means of 3D pseudocontinuous arterial spin-labeling MRI.
AJR Am J Roentgenol 2016;207:163-169.
73. Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage.
Radiology 1995;194:671-680.
74. Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment.
J Neurosurg 1995;82:166-179.
75. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis.
Neurology 1999;53:1537-1542.
76. Ferro JM, Canhão P. Acute treatment of cerebral venous and dural sinus thrombosis.
Curr Treat Options Neurol 2008;10:126-137.
77. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke 2011;42:1158-1192.
78. John S, Hajj-Ali RA. CNS vasculitis.
Semin Neurol 2014;34:405-412.
79. Heit JJ, Pastena GT, Nogueira RG, Yoo AJ, Leslie-Mazwi TM, Hirsch JA, et al. Cerebral angiography for evaluation of patients with CT angiogram-negative subarachnoid hemorrhage: an 11-year experience.
AJNR Am J Neuroradiol 2016;37:297-304.
80. Kannoth S, Iyer R, Thomas SV, Furtado SV, Rajesh BJ, Kesavadas C, et al. Intracranial infectious aneurysm: presentation, management and outcome.
J Neurol Sci 2007;256:3-9.
81. Lee WK, Mossop PJ, Little AF, Fitt GJ, Vrazas JI, Hoang JK, et al. Infected (mycotic) aneurysms: spectrum of imaging appearances and management.
Radiographics 2008;28:1853-1868.
82. Allen LM, Fowler AM, Walker C, Derdeyn CP, Nguyen BV, Hasso AN, et al. Retrospective review of cerebral mycotic aneurysms in 26 patients: focus on treatment in strongly immunocompromised patients with a brief literature review.
AJNR Am J Neuroradiol 2013;34:823-827.